SEARCH

SEARCH BY CITATION

References

  • Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158 (Suppl. 1): S1S254.
  • Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B et al. (2008). Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76: S1590S1611.
  • Banni S, Di Marzo V (2009). Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood. Mol Nutr Food Res 54: S82S92.
  • Bisht K, Wagner KH, Bulmer AC (2009). Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology (doi:10.1016/j.tox.2009.11.008). (ahead of print).
  • Bolognini D, Costa B, Maione S, Comelli F, Marini P, Di Marzo V et al. (2010). The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. Br J Pharmacol 160: 677687.
  • Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA et al. (2007). Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 848: S182S187.
  • Capasso R, Borrelli F, Cascio MG, Aviello G, Huben K, Zjawiony JK et al. (2008). Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. Br J Pharmacol 155: S681S689.
  • Chicca A, Raduner S, Pellati F, Strompen T, Altmann KH, Schoop R et al. (2009). Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts. Int Immunopharmacol 9: S850S858.
  • De Petrocellis L, Di Marzo V (2010). Non-CB(1), Non-CB(2) receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharmacol 5: 103121.
  • Di Marzo V (2008). Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7: S438S455.
  • Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E et al. (1998). Trick or treat from food endocannabinoids. Nature 396: S636S637.
  • Di Marzo V, Bisogno T, Petrocellis L (2007). Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol 14: S741S756.
  • Di Tomaso E, Beltramo M, Piomelli D (1996). Brain cannabinoids in chocolate. Nature 382: S677S678.
  • DuPont MS, Day AJ, Bennett RN, Mellon FA, Kroon PA (2004). Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr 58: S947S954.
  • Fichna J, Schicho R, Andrews CN, Bashashati M, Klompus M, McKay DM et al. (2009). Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterol Motil 21: S1326Se128.
  • Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA et al. (2004). Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90: S1011S1015.
  • Gertsch J (2008). Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action? Commun Integr Biol 1: S26S28.
  • Gertsch J (2009). How scientific is the science in ethnopharmacology: historical perspectives and epistemiological problems. J Ethnopharmacol 122: S177S183.
  • Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ et al. (2008). Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105: S9099S9104.
  • Gertsch J, Raduner S, Altmann KH (2006). New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors. J Recept Signal Transduct Res 26: S709S730.
  • King AR, Dotsey EY, Lodola A, Jung KM, Ghomian A, Qiu Y et al. (2009). Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem Biol 16: 10451052.
  • Korte G, Dreiseitel A, Schreier P, Oehme A, Locher A, Goeran H et al. (2009). An examination of anthocyanins' and anthocyanidins' affinity for cannabinoid receptors. J Med Food 12: S1407S1410.
  • Korte G, Dreiseitel A, Schreier P, Oehme A, Locher S, Geiger S et al. (2010). Tea catechins' affinity for human cannabinoid receptors. Phytomedicine 17: S19S22.
  • Landis-Piwowar KR, Dou QP (2008). Polyphenols: biological activities, molecular targets, and the effect of methylation. Curr Mol Pharmacol 1: S233S243.
  • Leonti M, Casu L, Raduner S, Cottiglia F, Floris C, Altmann K-H et al. (2010). Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin. Biochem Pharmacol (doi: 10.1016/j.bcp.2010.02.015). (accepted).
  • Maurelli S, Bisogno T, De Petrocellis L, Di Luccia A, Marino G, Di Marzo V (1995). Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase. FEBS Lett 377: S82S86.
  • Mechoulam R (1986). Interview with Prof. Raphael Mechoulam, codiscoverer of THC. Interview by Stanley Einstein. Int J Addict 21: S579S587.
  • O'Sullivan SE (2007). Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152: 576582.
  • Oesch S, Gertsch J (2009). Cannabis receptor ligands as potential anticancer agents – high hopes for new therapies? J Pharm Pharmacol 61: S839S853.
  • Pertwee RG (2005). The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J 7: E625E654.
  • Pertwee RG (2006). Cannabinoid pharmacology: the first 66 years. Br J Pharmacol 147: S163S171.
  • Pertwee RG (2009). Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156: S397S411.
  • Pertwee RG (2010). Receptors targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 17: 13601381.
  • Prather PL, Seely KA, Levi MS (2009). Notice of retraction. J Pharmacol Exp Ther 331: 1147.
  • Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B et al. (2006). Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type-2 receptor-dependent and –independent immunomodulatory effects. J Biol Chem 281: S14192S1S206.
  • Rios JL (2010). Effects of triterpenes on the immune system. J Ethnopharmacol 128: 114.
  • Rollinger JM, Schuster D, Danzl B, Schwaiger S, Markt P, Schmidtke M et al. (2009). In silico fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens. Planta Med 75: S195S204.
  • Ross RA (2009). The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30: S156S163.
  • Seely KA, Levi MS, Prather PL (2009). The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists. J Pharmacol Exp Ther 330: S31S39.
  • Shrestha R, Kim SC, Dyer JM, Dixon RA, Chapman KD (2006). Plant fatty acid (ethanol) amide hydrolases. Biochim Biophys Acta 1761: S324S334.
  • Spelman K, Iiams-Hauser K, Cech NB, Taylor EW, Smirnoff N, Wenner CA (2009). Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide. Int Immunopharmacol 9: S1260S1264.
  • Thors L, Alajakku K, Fowler CJ (2007). The ‘specific’ tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. Br J Pharmacol 150: S951S960.
  • Thors L, Belghiti M, Fowler CJ (2008). Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. Br J Pharmacol 155: S244S252.
  • Woelkart K, Dittrich P, Beubler E, Pinl F, Schoop R, Suter A et al. (2008). Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans. Planta Med 74: S651S656.
  • Yin H, Chu A, Li W, Wang B, Shelton F, Otero F et al. (2009). Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: S12328S12338.
  • Zimmer A, Racz I, Klauke AL, Markert A, Gertsch J (2009). Beta-caryophyllene, a phytocannabinoid acting on CB2 receptors. IACM 5th Conference on cannabinoids in medicine, 2-3. October, Cologne, Germany.